Polysaccharides from Platycodonis Radix ameliorated respiratory syncytial virus-induced epithelial cell apoptosis and inflammation through activation of miR-181a-mediated Hippo and SIRT1 pathways

Int Immunopharmacol. 2022 Mar:104:108510. doi: 10.1016/j.intimp.2021.108510. Epub 2022 Jan 6.

Abstract

Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis in young children, but there are few safe and effective treatments for this disease. Platycodonis Radix is widely used as an antitussive and expectorant drug for preventing various diseases in lower respiratory tract, in which the polysaccharides are one of the main bioactivity constituents. In this study, the protective effects of the P. Radix polysaccharides (PRP) against RSV-induced bronchiolitis in juvenile mice and RSV-induced apoptosis of epithelial HEp-2 cells were investigated. The results showed that PRP obviously decreased the levels of IL-1β, IL-4, IL-6, TNF-α, IFN-γ and TSLP in lung tissues, and reduced the number of inflammatory cells in bronchoalveolar lavage fluid (BALF) of RSV-infected mice. Furthermore, it reduced the apoptosis of RSV-infected HEp-2 cells and remarkably inhibited the mRNA expressions of RSV L gene, which indicated that PRP affected transcription and replication of RSV in host cells. Compared with that in RSV-infected group, miR-181a-5p in the PRP-treated group presented the highest relative abundance and its expression was violently reduced by approximately 30%. Mechanistically, PRP had the similar effects as miR-181a-5p antagomir on RSV-induced apoptosis and inflammation in HEp-2 cells via upregulating BCL2, MLL3 and SIRT1, which could be reversed by miR-181a-5p mimic. Therefore, it demonstrated that PRP not only protected against RSV-induced lung inflammation in mice but also inhibited apoptosis of RSV-infected HEp-2 cells via suppressing miR-181a-5p and transcriptionally activating Hippo and SIRT1 pathways.

Keywords: Apoptosis; BCL2; Inflammation; MLL3; Polysaccharides; SIRT1.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Apoptosis / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Cytokines / metabolism
  • Epithelial Cells / drug effects
  • Epithelial Cells / virology
  • Female
  • Hippo Signaling Pathway / drug effects
  • Humans
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Mice
  • Mice, Inbred BALB C
  • MicroRNAs
  • Plant Extracts*
  • Platycodon*
  • Polysaccharides / pharmacology
  • Polysaccharides / therapeutic use*
  • Respiratory Hypersensitivity / drug therapy*
  • Respiratory Hypersensitivity / genetics
  • Respiratory Hypersensitivity / metabolism
  • Respiratory Hypersensitivity / pathology
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Respiratory Syncytial Virus Infections / genetics
  • Respiratory Syncytial Virus Infections / metabolism
  • Respiratory Syncytial Virus Infections / pathology
  • Respiratory Syncytial Viruses
  • Sirtuin 1 / metabolism

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • MicroRNAs
  • Plant Extracts
  • Polysaccharides
  • mirn181 microRNA, mouse
  • platycodon root extract
  • Sirt1 protein, mouse
  • Sirtuin 1